[G23-09] Olopatadine/mometasone furoate (allergic rhinitis) – Addendum to Commission A22-125
Last updated 01.06.2023
Project no.:
G23-09
Commission:
Commission awarded on 27.04.2023 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Health Economics
Topic:
Airways and respiratory system
Note:
If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.
| Project no. | Title | Status |
|---|---|---|
| A22-125 | Olopatadine/mometasone (allergic rhinitis) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2023-06-01 A G-BA decision was published.